NCT04110028

Nicotinamide Riboside in Hospitalized Patients

Shorter Recovery Time After Critical Illness

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 57 (actual)
• Sponsor: Oslo University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Patients will receive oral nicotinamide riboside or placebo and clinical and paraclinical outcome will be determined

Detailed description

Patients experiencing acute illness will often have a prolonged recovery time. The cause of this is unknown, but certain factors, like age, duration, and graveness of the illness, is associated with prolonged recovery. In this study, we will investigate whether nicotinamide riboside can shorten the recovery phase and improve outcome after acute illness.

Conditions

• Inflammation
• Acute Illness

Interventions

Type	Name	Description
DRUG	Nicotinamide riboside	Nicotinamide riboside in different doses
DRUG	Placebo	Placebo

Timeline

• Start date: 2019-10-01
• Primary completion: 2022-12-01
• Completion: 2023-12-01
• First posted: 2019-10-01
• Last updated: 2024-05-20

Locations

1 site across 1 country: Norway